Terms: = Pancreatic cancer AND DNAJB1, HSPF1, 3337, ENSG00000132002, P25685, Hdj1, Hsp40 AND Treatment
5 results:
1. Leveraging the Structure of DNAJA1 to Discover Novel Potential pancreatic cancer Therapies.
Roth HE; De Lima Leite A; Palermo NY; Powers R
Biomolecules; 2022 Sep; 12(10):. PubMed ID: 36291603
[TBL] [Abstract] [Full Text] [Related]
2. ATF3 Coordinates Antitumor Synergy between Epigenetic Drugs and Protein Disulfide Isomerase Inhibitors.
Duncan RM; Reyes L; Moats K; Robinson RM; Murphy SA; Kaur B; Stessman HAF; Dolloff NG
Cancer Res; 2020 Aug; 80(16):3279-3291. PubMed ID: 32561529
[TBL] [Abstract] [Full Text] [Related]
3. dnajb1-PRKACA fusions occur in oncocytic pancreatic and biliary neoplasms and are not specific for fibrolamellar hepatocellular carcinoma.
Vyas M; Hechtman JF; Zhang Y; Benayed R; Yavas A; Askan G; Shia J; Klimstra DS; Basturk O
Mod Pathol; 2020 Apr; 33(4):648-656. PubMed ID: 31676785
[TBL] [Abstract] [Full Text] [Related]
4. Regulation of growth hormone biosynthesis by Cdk5 regulatory subunit associated protein 1-like 1 (CDKAL1) in pituitary adenomas.
Takesue Y; Wei FY; Fukuda H; Tanoue Y; Yamamoto T; Chujo T; Shinojima N; Yano S; Morioka M; Mukasa A; Kuratsu J; Tomizawa K
Endocr J; 2019 Sep; 66(9):807-816. PubMed ID: 31189758
[TBL] [Abstract] [Full Text] [Related]
5. Fibrolamellar Hepatocellular Carcinoma with Multiple Lung Metastases Treated with Multidisciplinary Therapy.
Tanaka H; Hijioka S; Iwaya H; Mizuno N; Kuwahara T; Okuno N; Ito A; Kuraoka N; Matsumoto S; Obata M; Kurita Y; Yasuda M; Shimizu Y; Kuroda H; Sato Y; Haneda M; Sasaki E; Yatabe Y; Hara K
Intern Med; 2018 Dec; 57(24):3537-3543. PubMed ID: 30101933
[TBL] [Abstract] [Full Text] [Related]
